Beam Therapeutics Inc. BEAM
Set alert
At close · Nov 2
After hours · Nov 2, 6:54 PM ET
- YTD
- -6.67%
- 1 year
- +3.44%
- Open
- 27.45
- Prev close
- 27.23
- Mkt cap
- 2.67B
- Vol
- 1.45M
- Avg vol
- 1.84M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 25.79
- High
- 27.67
- Forward P/E
- -5.45
- Beta
- 2.22
- Short ratio
- 13.87
- Inst. own
- 107.81%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 25.93
- 200-d avg
- 28.14
- 1y target
- 49.38
MAX chart
Events in this range
- Aug 5, 2025Earnings: -1; estimate -1.04; surprise 3.85%
- Nov 4, 2025Earnings: -1.1; estimate -0.98; surprise -12.24%
- Feb 24, 2026Earnings: -0.1; estimate -1.13; surprise 91.15%
- May 7, 2026Earnings: -0.91; estimate -0.87; surprise -4.6%
- Aug 4, 2026Earnings: -1.18; estimate -1.11; surprise -6.31%
- Aug 25, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Sep 9, 2026Rating: Wedbush · Outperform → Outperform
- Oct 14, 2026Rating: Wedbush · Outperform → Outperform
- Oct 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 28, 2026Rating: Wedbush · Outperform → Outperform
- Oct 29, 2026Rating: Canaccord Genuity · Buy → Buy
- Nov 3, 2026Earnings: —; estimate -1.15; surprise —%
Signals (146)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
Newest 20 of 146.
Discussion (3)
Sign in to join the discussion
New CRISPR/Cas9 patent issued to Carribou Bio $CRBU
$CRBU
Take a look at Caribou Biosciences.
Leader in CRISPR Gene editing. Cure to all diseases.
Founded by Nobel winner Jennifer Doudna and CEO Rachel Haurwitz.
Market cap 1.3 Billion.
They have 14,453,932 shares of Intellia (NTLA). Worth $2.5 Billion alone. Check out filings:
https://www.sec.gov/edgar/browse/?CIK=1619856&owner=exclude
They have about $500 Million in cash from recent IPO.
Listen to The Code Breaker by Walter Isaacson on Audible. https://www.audible.com/pd?asin=179711705X&source_code=ASSORAP0511160006
Check out patents:
Working on cure for cancer.
This has potential for x 1000
Do your own due diligence.
Good luck
Buy low sell higher 5 years later
